Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT00410033
First received: December 11, 2006
Last updated: December 21, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Publications:
Ludvigsson J, Mersebach H, Kanc Hanzel K, Holmberg H. Treatment with insulin aspart versus human insulin in children and adolescents with newly diagnosed type 1 diabetes. EASD 2007; 50(Suppl 1): S380
Holmberg H, Mersebach H, Hanzel KK, Ludvigsson J. Antibody response to insulin in children and adolescents with newly diagnosed type 1 diabetes. ADA 2007; 56 (Suppl. 1): A476 (1885-P

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):